Multi-target therapies may address combined hypertension and dyslipidemia pathophysiology
Multi-Target Therapies May Address Combined Hypertension and High Cholesterol
This systematic review synthesizes evidence on synergistic mechanisms of hypertension and dyslipidemia, highlighting the RAAS/PPAR axis, AMP…
Combining treatments like statins and RAAS inhibitors may offer a more precise way to manage both high blood pressure and cholesterol levels…
Narrative review discusses hypertension risks in oncology patients receiving VEGF pathway inhibitors
Blood Pressure Spikes During Cancer Therapy: What Patients Need to Know
This narrative review examines hypertension management in oncology patients treated with VEGF pathway inhibitors, RAAS inhibitors, and calci…
High blood pressure is a common side effect of certain cancer drugs, but early detection and the right medications can protect your heart.
24-hour diastolic BP variability linked to renal decline in diabetic kidney disease
Why Your Blood Pressure Swings Matter More Than Numbers
This retrospective cohort study of 2143 patients with diabetic kidney disease found that each 1 mmHg increase in 24-hour diastolic blood pre…
Stability matters more than the number itself when protecting kidneys.